A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor	Recruiting	Phase 1	2026-03-19		NCT04192344

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abbisko Therapeutics Co, Ltd	22

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Jishuitan Hospital	Beijing	China	3
Hebei Medical University Third Hospital	Shijiazhuang	China	3
Henan Cancer Hospital	Zhengzhou	China	98
Huashan Hospital of Fudan University	Shanghai	China	2
Jiangsu Province Hospital	Nanjing	China	37
Liaoning Cancer Hospital	Shenyang	China	15
MD Anderson Cancer Center	Houston	United States	589
Nanjing Drum Tower Hospital	Nanjing	China	33
Precision NextGen Oncology	Beverly Hills	United States	9
SCRI at HealthOne	Denver	United States	1
Shanghai Sixth People's Hospital	Shanghai	China	9
The First Affiliated Hospital of Sun Yat-sen University	Guangdong	China	1
The First Affiliated Hospital of Zhengzhou Universtity	Zhengzhou	China	1
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	22
The Winship Cancer Institute of Emory University	Atlanta	United States	2
West China Hospital of Sichuan University	Chengdu	China	68
Xi'an Hong Hui Hospital	Xian	China	1